+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunohematology Market by Product Type, Technology, Test Type, Automation Level, Application - Global Forecast 2026-2032- Product Image
Immunohematology Market by Product Type, Technology, Test Type, Automation Level, Application - Global Forecast 2026-2032- Product Image
Sale

Immunohematology Market by Product Type, Technology, Test Type, Automation Level, Application - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5454916
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Immunohematology Market is projected to reach USD 2.60 Billion in 2026. It is expected to continue growing at a CAGR of 8.54%, reaching USD 4.27 Billion by 2032.

Immunohematology sits at the center of transfusion medicine, transplant support, maternal-fetal care, oncology, emergency medicine, and complex surgery. The field encompasses blood group serology, red cell antibody screening and identification, crossmatching, hemolytic disease testing, donor-recipient compatibility, molecular blood typing, and hemovigilance workflows that protect patients from preventable transfusion reactions.

Demand is supported by durable clinical fundamentals: the WHO reports more than 118 million blood donations are collected globally each year, while aging populations, trauma systems, cancer care, organ transplantation, and chronic disease management continue to increase the need for safe, compatible blood components. As hospitals and reference laboratories face workforce shortages and rising quality expectations, immunohematology is moving from manual serology toward automated, data-connected, and genomics-enabled testing models.

Transformative Shifts in the Landscape

The immunohematology landscape is being reshaped by three converging shifts: automation, molecular precision, and connected quality management. Automated blood bank analyzers and column agglutination or solid-phase platforms are reducing hands-on variability, improving turnaround time, and supporting standardized interpretation across hospital networks and centralized laboratories.

At the same time, molecular immunohematology is expanding beyond specialized reference settings. Red cell genotyping is increasingly used for patients requiring chronic transfusion, including those with sickle cell disease, thalassemia, and oncology-related anemia, where extended antigen matching can reduce alloimmunization risk. Regulatory modernization, electronic crossmatch adoption, and stronger hemovigilance systems are also pushing laboratories to integrate instruments, laboratory information systems, donor databases, and clinical decision-support tools.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is expected to have a cumulative impact across immunohematology by improving pattern recognition, workflow prioritization, inventory forecasting, and decision support. AI-enabled image analysis can assist with agglutination grading, while machine learning models can help flag discrepant results, predict blood utilization, and optimize blood component availability across hospital systems.

The greatest value will come when AI is governed as a validated clinical support layer rather than a replacement for laboratory expertise. Successful adoption requires traceable datasets, bias assessment across diverse blood group distributions, cybersecurity safeguards, and compliance with CLIA, CAP, FDA, EU IVDR, ISO 15189, and local blood safety requirements. Laboratories that combine automation, rules-based algorithms, and human review are positioned to improve consistency without compromising patient safety.

Key Regional Insights

Asia-Pacific is emerging as a high-priority immunohematology region due to expanding hospital infrastructure, rising surgical volumes, national blood service upgrades, and broader adoption of automated blood bank testing in China, India, Japan, South Korea, and Australia. The region also faces a substantial transfusion burden linked to thalassemia, obstetric care, trauma, oncology, and chronic disease management, reinforcing the need for standardized blood grouping, antibody screening, compatibility testing, and hemovigilance. North America remains a mature innovation hub, supported by advanced transfusion services, reference laboratories, robust accreditation, and early adoption of molecular typing, electronic crossmatch workflows, and laboratory information system integration.

Europe benefits from strong national blood systems, EU regulatory harmonization, established quality standards, and high awareness of hemovigilance, with immunohematology laboratories increasingly focused on validated assays, traceability, and data governance under evolving in vitro diagnostic requirements. Latin America is improving access through centralized blood banks, national blood safety initiatives, and public-private investments in Brazil and Mexico, while uneven infrastructure continues to create demand for scalable automation and standardized testing. The Middle East is strengthening transfusion capacity through GCC healthcare modernization, tertiary hospital expansion, transplant services, oncology care, and medical tourism. Africa continues to prioritize blood availability, infectious disease screening, maternal health, pediatric transfusion safety, and emergency care, creating demand for cost-efficient immunohematology solutions suited to decentralized and resource-constrained settings.

Key Group Insights

ASEAN markets are advancing through hospital network expansion, public blood service modernization, medical tourism, and regional demand for reliable pretransfusion testing across diverse healthcare systems. The group’s high population base and growing access to surgery, oncology, and maternal care are increasing the importance of standardized blood grouping, antibody screening, and quality assurance. The GCC is investing in high-acuity care, transplant programs, oncology centers, digital health infrastructure, and nationally coordinated healthcare modernization, which supports adoption of automated immunohematology platforms, laboratory connectivity, and quality management systems.

The European Union is shaped by IVDR implementation, cross-border quality expectations, national hemovigilance programs, and established transfusion guidelines, creating demand for validated assays, traceable data, and compliant laboratory workflows. BRICS countries represent a large-volume opportunity driven by population scale, healthcare access expansion, blood service modernization, and domestic manufacturing ambitions across diagnostics and healthcare technologies. G7 markets remain the benchmark for premium automation, molecular immunohematology, regulatory rigor, and advanced reference testing, while NATO countries emphasize resilient blood supply chains, interoperability, emergency preparedness, and continuity of transfusion services for civilian and defense medical systems.

Key Country Insights

The United States leads in advanced transfusion medicine, red cell genotyping, reference testing, electronic crossmatch adoption, and FDA-regulated blood safety practices, while Canada emphasizes nationally coordinated blood services and high-quality hospital transfusion programs. Mexico is strengthening centralized testing capacity and improving blood safety standardization across public and private healthcare settings. Brazil is expanding transfusion infrastructure and remains Latin America’s largest healthcare system, with demand supported by complex surgery, oncology care, trauma services, and chronic disease management.

In Europe, the United Kingdom maintains a highly structured transfusion environment supported by national blood services, hemovigilance, and specialized reference testing. Germany and France are notable for sophisticated transfusion networks, strong diagnostics capabilities, and life sciences expertise, while Italy and Spain maintain mature hospital-based transfusion services supported by established quality systems. Russia has broad hospital demand and transfusion needs across a large geography, although procurement, sanctions-related constraints, and technology-access limitations can affect modernization. In Asia-Pacific, China is scaling blood service modernization and laboratory automation across major urban centers, India is addressing access and standardization across a large and diverse patient base, Japan and South Korea emphasize advanced automation, quality assurance, and aging-population care, and Australia maintains a highly regulated, consolidated transfusion environment with strong national oversight and traceability.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize platforms that combine automation, assay reliability, interoperability, and regulatory readiness. Vendors and laboratories can differentiate by integrating immunohematology analyzers with laboratory information systems, enabling electronic crossmatch workflows, supporting remote quality review, and offering scalable solutions for both centralized blood centers and hospital transfusion services.

Strategic investment should focus on molecular blood group typing, AI-assisted interpretation, cybersecurity, staff training, and evidence generation that demonstrates reduced turnaround time, fewer manual errors, stronger traceability, and improved patient outcomes. Partnerships with blood services, hospital networks, reference laboratories, and public health agencies will be critical for expanding access while maintaining compliance, workflow efficiency, and clinical confidence.

Research Methodology

This executive summary is developed using a structured methodology that combines secondary research, expert validation, and data triangulation. Sources include public health agencies, blood safety organizations, regulatory bodies, peer-reviewed transfusion medicine literature, product documentation, accreditation standards, and clinical practice guidelines.

The analysis evaluates demand drivers, technology adoption, regulatory shifts, regional healthcare infrastructure, and end-user requirements across hospitals, blood banks, reference laboratories, and academic medical centers. Insights are validated by comparing multiple authoritative sources and by assessing consistency with observable industry behavior, including automation adoption, molecular testing expansion, hemovigilance priorities, regulatory compliance, and digital laboratory transformation.

Conclusion

Immunohematology is entering a more automated, data-rich, and precision-driven phase as healthcare systems seek safer transfusion practices, faster compatibility testing, and stronger blood supply resilience. The convergence of serology, molecular diagnostics, AI-enabled decision support, and integrated laboratory information systems is redefining how blood banks manage complexity and risk.

Organizations that invest in validated automation, regulatory compliance, workforce enablement, and interoperable data infrastructure will be best positioned to strengthen clinical performance. The outlook remains anchored in essential clinical need: every transfusion decision depends on accurate immunohematology testing, making innovation in this field central to patient safety and modern healthcare delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Immunohematology Market, by Product Type
7.1. Analyzers & Systems
7.1.1. Fully-Automated
7.1.2. Semi-Automated
7.2. Reagents & Kits
8. Immunohematology Market, by Technology
8.1. Gel Card Technology
8.2. Solid Phase Technology
8.3. Tube Testing
9. Immunohematology Market, by Test Type
9.1. Blood Typing
9.2. Antibody Screening & Identification
9.3. Crossmatching
9.4. Antiglobulin Testing
9.5. Donor Screening Tests
10. Immunohematology Market, by Automation Level
10.1. Manual
10.2. Semi-Automated
10.3. Fully Automated
11. Immunohematology Market, by Application
11.1. Antibody Screening
11.2. Blood Transfusion
11.3. Disease Diagnosis
11.4. Pregnancy
12. Asia-Pacific Immunohematology Market
13. North America Immunohematology Market
14. Latin America Immunohematology Market
15. Europe Immunohematology Market
16. Middle East Immunohematology Market
17. Africa Immunohematology Market
18. ASEAN Immunohematology Market
19. GCC Immunohematology Market
20. European Union Immunohematology Market
21. BRICS Immunohematology Market
22. G7 Immunohematology Market
23. NATO Immunohematology Market
24. United States Immunohematology Market
25. Canada Immunohematology Market
26. Mexico Immunohematology Market
27. Brazil Immunohematology Market
28. United Kingdom Immunohematology Market
29. Germany Immunohematology Market
30. France Immunohematology Market
31. Russia Immunohematology Market
32. Italy Immunohematology Market
33. Spain Immunohematology Market
34. China Immunohematology Market
35. India Immunohematology Market
36. Japan Immunohematology Market
37. Australia Immunohematology Market
38. South Korea Immunohematology Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Abbott Laboratories
40.2. Atlas Medical GmbH
40.3. Beckman Coulter, Inc.
40.4. Bio-Rad Laboratories, Inc.
40.5. bioMérieux SA
40.6. Diagast SAS
40.7. DiaSorin S.p.A.
40.8. F. Hoffmann-La Roche Ltd.
40.9. Grifols, S.A.
40.10. Immucor, Inc.
40.11. J. Mitra & Co. Pvt. Ltd.
40.12. Merck KGaA
40.13. Nova Biomedical Corporation
40.14. Ortho Clinical Diagnostics
40.15. QuidelOrtho Corporation
40.16. Quotient Limited
40.17. Sanquin Reagents B.V.
40.18. Siemens Healthineers AG
40.19. Span Diagnostics Ltd.
40.20. Sysmex Corporation
40.21. Thermo Fisher Scientific Inc.
40.22. Trinity Biotech plc
40.23. Tulip Diagnostics (P) Ltd.
List of Figures
FIGURE 1. GLOBAL IMMUNOHEMATOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IMMUNOHEMATOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL IMMUNOHEMATOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL IMMUNOHEMATOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2032 (%)
FIGURE 21. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IMMUNOHEMATOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IMMUNOHEMATOLOGY MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL IMMUNOHEMATOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANALYZERS & SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANALYZERS & SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANALYZERS & SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL FULLY-AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL FULLY-AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL FULLY-AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GEL CARD TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GEL CARD TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GEL CARD TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SOLID PHASE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SOLID PHASE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SOLID PHASE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TUBE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TUBE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TUBE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BLOOD TYPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BLOOD TYPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BLOOD TYPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANTIBODY SCREENING & IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANTIBODY SCREENING & IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANTIBODY SCREENING & IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CROSSMATCHING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CROSSMATCHING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CROSSMATCHING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANTIGLOBULIN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANTIGLOBULIN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANTIGLOBULIN TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DONOR SCREENING TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DONOR SCREENING TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DONOR SCREENING TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MANUAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MANUAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MANUAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SEMI-AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL FULLY AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL FULLY AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL FULLY AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANTIBODY SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANTIBODY SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANTIBODY SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BLOOD TRANSFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BLOOD TRANSFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BLOOD TRANSFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PREGNANCY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PREGNANCY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PREGNANCY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 72. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. EUROPE IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 94. EUROPE IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 95. EUROPE IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 96. EUROPE IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 97. EUROPE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 108. AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 109. AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 110. AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 111. AFRICA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. ASEAN IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. ASEAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 114. ASEAN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 115. ASEAN IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. ASEAN IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 117. ASEAN IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 118. ASEAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. GCC IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GCC IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 121. GCC IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 122. GCC IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 123. GCC IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 124. GCC IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 125. GCC IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 132. EUROPEAN UNION IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. BRICS IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. BRICS IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. BRICS IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 136. BRICS IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 137. BRICS IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 138. BRICS IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 139. BRICS IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. G7 IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. G7 IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. G7 IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 143. G7 IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 144. G7 IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 145. G7 IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 146. G7 IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. NATO IMMUNOHEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. NATO IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. NATO IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 150. NATO IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. NATO IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 152. NATO IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 153. NATO IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 155. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 156. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 157. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 158. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 159. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. CANADA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 162. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 164. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 165. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 166. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 167. CANADA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 169. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 170. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 171. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 173. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 174. MEXICO IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 176. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 178. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 180. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 181. BRAZIL IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 183. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 184. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 185. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 187. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 188. UNITED KINGDOM IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 190. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 192. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 194. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 195. GERMANY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 197. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 198. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 199. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 200. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 201. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 202. FRANCE IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 204. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 205. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 206. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 207. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 208. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 209. RUSSIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. ITALY IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 211. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 213. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 215. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 216. ITALY IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 217. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 220. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 221. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 222. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 223. SPAIN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. CHINA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 225. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 226. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 227. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 228. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 229. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 230. CHINA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. INDIA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 232. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 233. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 234. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 235. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 236. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 237. INDIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 239. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 240. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 241. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 242. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 243. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 244. JAPAN IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 245. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 246. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 248. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 249. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 250. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 251. AUSTRALIA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 253. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 254. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY ANALYZERS & SYSTEMS, 2018-2032 (USD MILLION)
TABLE 255. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 256. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 257. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
TABLE 258. SOUTH KOREA IMMUNOHEMATOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Immunohematology market report include:
  • Abbott Laboratories
  • Atlas Medical GmbH
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Diagast SAS
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Grifols, S.A.
  • Immucor, Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Merck KGaA
  • Nova Biomedical Corporation
  • Ortho Clinical Diagnostics
  • QuidelOrtho Corporation
  • Quotient Limited
  • Sanquin Reagents B.V.
  • Siemens Healthineers AG
  • Span Diagnostics Ltd.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc
  • Tulip Diagnostics (P) Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.6 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.27 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Immunohematology Market Size, Share, Trends and Forecast by Product, Technology, Application, End-User, and Region, 2026-2034 - Product Image

Immunohematology Market Size, Share, Trends and Forecast by Product, Technology, Application, End-User, and Region, 2026-2034

  • Report
  • 149 Pages
  • Global
From
Immunohematology Analyzers and Reagents - Global Strategic Business Report - Product Image

Immunohematology Analyzers and Reagents - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Immunohematology Market Report 2026 - Product Image

Immunohematology Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Immunohematology Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Immunohematology Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
South Africa IVD Market Forecasts: Cancer IVD, Chemistry, Coagulation, Endocrine, Flow Cytometry, Hematology, Immunodiagnostic, ImmunoHematology, Immunodiagnostic, Immunoprotein, Molecular IVD, TDM - Product Image

South Africa IVD Market Forecasts: Cancer IVD, Chemistry, Coagulation, Endocrine, Flow Cytometry, Hematology, Immunodiagnostic, ImmunoHematology, Immunodiagnostic, Immunoprotein, Molecular IVD, TDM

  • Report
  • South Africa
From

About the Immunohematology Market

Immunohematology is a branch of medicine that focuses on the study of blood and its components, particularly the antigens and antibodies that are involved in the immune system. It is a key component of transfusion medicine, which is the practice of transfusing blood and its components to patients in need. Immunohematology is also used in the diagnosis and treatment of various blood disorders, such as hemophilia and sickle cell anemia. Immunohematology is a major part of the pharmaceutical industry, as it is used to develop and manufacture drugs and treatments for blood-related diseases. It is also used to develop and manufacture blood products, such as red blood cells, platelets, and plasma, for transfusion. Additionally, immunohematology is used to develop and manufacture diagnostic tests for blood-related diseases. Some companies in the immunohematology market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.